Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc.（LXRX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lxrx · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Hold
14 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$6.00
+214.1% upside
Low
$6.00
Median: $6 · Last Close: $1.91
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.81 | ↓ 5.00% |
1-day model range: $1.8–$1.83. Peak: $1.83 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | +120.0% |
| 2028 | $7 | +265.2% |
| 2029 | $10 | +397.8% |
| 2030 | $11 | +497.1% |
| 2031 | — | +562.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LXRX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | Citigroup | Maintains | Buy→Buy |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | Citigroup | Maintains | Buy→Buy |
| 2026-03-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-07 | Citigroup | Maintains | Buy→Buy |
| 2025-06-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | Needham | Maintains | Hold→Hold |
| 2025-03-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lexicon Pharmaceuticals, Inc. (LXRX) stock. Of the recent 80 rating actions, 5 were upgrades and 11 were downgrades. 14 analysts currently cover LXRX.
分析师推荐趋势
LXRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$38M
↓ 49.9% YoY
Revenue Next Year
$20M
↓ 47.2% YoY
EPS This Year
$-0.16
EPS Next Year
$-0.21
↑ 30.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast LXRX EPS of $-0.16 for the current fiscal year, based on estimates from 3 analysts. The LXRX revenue forecast is $38M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LXRX 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LXRX 的共识目标价为 $6.00（+214.1% 上行空间），分析师共识为 Hold。
LXRX 的短期预测（明日）为 $1.81（-5.00%）。 LXRX 对 2027 年的股价预测均值为 $4。 LXRX 对 2030 年的预测区间为 $10–$13。
Lexicon Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 LXRX。LXRX 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 36% 对应 Hold 共识。
常见问题
LXRX 预测 · 8 个问题根据 14 位华尔街分析师，LXRX 的 12 个月平均目标价为 $6.00，最高 $6.00、最低 $6.00。若有图表，中位目标价可在上方查看。相对当前价 $1.91，隐含约 +214.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.